Further analysis revealed higher proportions of immune-infiltrating cells, including CD4+ T cells, dendritic cells, natural killer T cells, regulatory T cells, and helper T cells, in patients with the A subtype of GBM. This evidence concerns the gene CD4 and glioblastoma.